JP2007536906A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007536906A5 JP2007536906A5 JP2006541888A JP2006541888A JP2007536906A5 JP 2007536906 A5 JP2007536906 A5 JP 2007536906A5 JP 2006541888 A JP2006541888 A JP 2006541888A JP 2006541888 A JP2006541888 A JP 2006541888A JP 2007536906 A5 JP2007536906 A5 JP 2007536906A5
- Authority
- JP
- Japan
- Prior art keywords
- binding affinity
- gag binding
- less
- fold
- help
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000035118 modified proteins Human genes 0.000 description 2
- 108091005573 modified proteins Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0195203A AT412785B (de) | 2003-12-04 | 2003-12-04 | Gag-bindungsproteine |
| ATA1952/2003 | 2003-12-04 | ||
| PCT/EP2004/013670 WO2005054285A1 (en) | 2003-12-04 | 2004-12-02 | Gag binding proteins |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012040123A Division JP2012139226A (ja) | 2003-12-04 | 2012-02-27 | Gag結合蛋白質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007536906A JP2007536906A (ja) | 2007-12-20 |
| JP2007536906A5 true JP2007536906A5 (cg-RX-API-DMAC10.html) | 2012-04-12 |
| JP4980721B2 JP4980721B2 (ja) | 2012-07-18 |
Family
ID=33494536
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006541888A Expired - Fee Related JP4980721B2 (ja) | 2003-12-04 | 2004-12-02 | Gag結合蛋白質 |
| JP2012040123A Pending JP2012139226A (ja) | 2003-12-04 | 2012-02-27 | Gag結合蛋白質 |
| JP2012086483A Pending JP2012165747A (ja) | 2003-12-04 | 2012-04-05 | Gag結合蛋白質 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012040123A Pending JP2012139226A (ja) | 2003-12-04 | 2012-02-27 | Gag結合蛋白質 |
| JP2012086483A Pending JP2012165747A (ja) | 2003-12-04 | 2012-04-05 | Gag結合蛋白質 |
Country Status (20)
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT412785B (de) * | 2003-12-04 | 2005-07-25 | Kungl Andreas J Dr | Gag-bindungsproteine |
| ES2543341T3 (es) | 2005-09-13 | 2015-08-18 | National Research Council Of Canada | Métodos y composiciones para modular la actividad de células tumorales |
| CN100366637C (zh) * | 2005-11-17 | 2008-02-06 | 中国人民解放军第四军医大学 | 人白细胞介素8拮抗蛋白及其制备方法 |
| US9422356B2 (en) * | 2006-01-31 | 2016-08-23 | Republic Of Korea (Republic Of National Fisheries Research And Development Institute) | Artificial signal peptide for expressing an insoluble protein as a soluble active form |
| JP5173838B2 (ja) | 2006-02-13 | 2013-04-03 | アレシア・バイオセラピューティクス・インコーポレーテッド | 骨リモデリングのプロセスと関係があるポリヌクレオチドおよびポリペプチド配列 |
| US8168181B2 (en) | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
| EP1894571A1 (en) * | 2006-08-29 | 2008-03-05 | Protaffin Biotechnologie AG | Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection |
| US20100075918A1 (en) * | 2006-12-08 | 2010-03-25 | Lokeshwar Vinata B | Hyaluronidase inhibitors as anti-cancer agents |
| AT504685B1 (de) * | 2006-12-20 | 2009-01-15 | Protaffin Biotechnologie Ag | Fusionsproteine |
| CA2686817A1 (en) * | 2007-05-07 | 2009-02-19 | Peptimmune, Inc. | Methods for the directed expansion of epitopes for use as antibody ligands |
| EP2042516A1 (en) * | 2007-09-27 | 2009-04-01 | Protaffin Biotechnologie AG | Glycosaminoglycan-antagonising MCP-1 mutants and methods of using same |
| EP2185719B1 (en) | 2007-08-02 | 2013-11-13 | NovImmune SA | Anti-rantes antibodies and methods of use thereof |
| EP2053060A1 (en) * | 2007-10-24 | 2009-04-29 | Protaffin Biotechnologie AG | SDF-1-based glyocosaminoglycan antagonists and methods of using same |
| US8314212B2 (en) * | 2008-02-08 | 2012-11-20 | Lindsey Miles | Plasminogen receptor PLG-RKT and antibodies thereof |
| US20120046218A1 (en) | 2009-01-30 | 2012-02-23 | Protaffin Biotechnologie Ag | Glycosaminoglycan-antagonising mcp-i mutants and methods of using same |
| WO2011029931A1 (en) | 2009-09-11 | 2011-03-17 | Protaffin Biotechnologie Ag | Composition for treatment of cxcl8-mediated lung inflammation |
| CA2928846A1 (en) | 2009-11-24 | 2011-06-03 | Alethia Biotherapeutics Inc. | Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume |
| GB201012603D0 (en) * | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Protein purification |
| WO2012123585A1 (en) | 2011-03-16 | 2012-09-20 | Protaffin Biotechnologie Ag | Fgfr1-based antagonists with improved glycosaminoglycan affinity and methods of using same |
| EP2729487A2 (en) | 2011-07-08 | 2014-05-14 | Protaffin Biotechnologie AG | Novel sdf-1-based glycosaminoglycan antagonist and methods of using same |
| CA2862739A1 (en) | 2012-02-22 | 2013-08-29 | Alethia Biotherapeutics Inc. | Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer |
| AU2013293062A1 (en) | 2012-07-19 | 2014-07-24 | Alethia Biotherapeutics Inc. | Anti-Siglec-15 antibodies |
| WO2014079957A1 (de) * | 2012-11-23 | 2014-05-30 | Bayer Cropscience Ag | Selektive inhibition der ethylensignaltransduktion |
| US9493528B2 (en) * | 2013-01-10 | 2016-11-15 | Supadelixir Inc. | Microphthalmia-associated transcription factor-derived peptide and composition containing same |
| WO2015110526A1 (en) * | 2014-01-22 | 2015-07-30 | Antagonis Biotherapeutics Gmbh | Novel glycosaminoglycan-antagonising fusion proteins and methods of using same |
| WO2021038033A1 (en) | 2019-08-29 | 2021-03-04 | Antagonis Biotherapeutics Gmbh | T-cell mobilizing cxcl10 mutant with increased glycosaminoglycan binding affinity |
| CN110791523B (zh) * | 2019-12-13 | 2022-05-10 | 南京农业大学 | 一种棉花抗旱相关基因GhRCHY1及其应用 |
| WO2023003984A2 (en) * | 2021-07-20 | 2023-01-26 | Oregon Health & Science University | Label-free detection of protease activity |
| KR20250040765A (ko) * | 2023-09-15 | 2025-03-25 | (주)케어젠 | 펩타이드를 유효성분으로 하는 발모 촉진 또는 탈모증의 억제, 예방 또는 개선용 조성물 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4960691A (en) * | 1986-09-29 | 1990-10-02 | Abbott Laboratories | Chromatographic test strip for determining ligands or receptors |
| US5234911A (en) * | 1990-07-09 | 1993-08-10 | Gist-Brocades, N.V. | Substance with interleukin-8 inhibiting activity and process for its preparation |
| AU8947791A (en) | 1990-11-01 | 1992-05-26 | Scripps Research Institute, The | Glycosaminoglycan-targeted fusion proteins, their design, construction and compositions |
| EP0607777B1 (de) * | 1993-01-08 | 1998-12-09 | Hoechst Aktiengesellschaft | Verwendung von Leflunomid zur Hemmung von Interleukin 8 |
| JP2694321B2 (ja) * | 1993-03-10 | 1997-12-24 | 大塚製薬株式会社 | インターロイキン−1阻害剤 |
| US5527546A (en) * | 1994-08-10 | 1996-06-18 | Bayer Corporation | Human interleukin 6 inhibitor |
| US5866402A (en) * | 1995-05-05 | 1999-02-02 | Chiron Corporation | Chimeric MCP and DAF proteins with cell surface localizing domain |
| JPH1045602A (ja) * | 1996-07-31 | 1998-02-17 | Motoyasu Murakami | ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−8産生阻害剤 |
| US6852696B2 (en) * | 1999-03-26 | 2005-02-08 | The University Of Texas System | Inhibitors of glycosaminoglycans |
| WO2002020715A2 (en) | 2000-09-05 | 2002-03-14 | Biosight Ltd. | Peptide conjugated anti-cancer prodrugs |
| UA77950C2 (en) * | 2000-10-04 | 2007-02-15 | Applied Research Systems | Use of mutants of cc chemokines for treatment of multiple sclerosis |
| GB0110430D0 (en) * | 2001-04-27 | 2001-06-20 | Medical Res Council | Protein variants and uses thereof |
| JP2003063980A (ja) * | 2001-08-28 | 2003-03-05 | Noevir Co Ltd | Rantes産生阻害剤 |
| US6982170B1 (en) * | 2001-12-17 | 2006-01-03 | Maine Medical Center Research Institute | Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1 |
| JP2003306438A (ja) * | 2002-02-18 | 2003-10-28 | Shiseido Co Ltd | ケモカイン発現阻害剤 |
| JP2003267887A (ja) * | 2002-03-15 | 2003-09-25 | Shiseido Co Ltd | ケモカイン発現抑制皮膚外用剤 |
| IL164376A0 (en) * | 2002-04-03 | 2005-12-18 | Applied Research Systems | Ox4or binding agents, their preparation and pharmaceutical compositions containing them |
| CN1665839A (zh) * | 2002-04-10 | 2005-09-07 | 应用研究系统Ars股份公司 | Mcp蛋白质的新型拮抗剂 |
| AT412785B (de) * | 2003-12-04 | 2005-07-25 | Kungl Andreas J Dr | Gag-bindungsproteine |
-
2003
- 2003-12-04 AT AT0195203A patent/AT412785B/de not_active IP Right Cessation
-
2004
- 2004-12-02 JP JP2006541888A patent/JP4980721B2/ja not_active Expired - Fee Related
- 2004-12-02 ES ES06117339T patent/ES2330362T3/es not_active Expired - Lifetime
- 2004-12-02 BR BRPI0416544-6A patent/BRPI0416544A/pt not_active IP Right Cessation
- 2004-12-02 EP EP10180909A patent/EP2311866A1/en not_active Withdrawn
- 2004-12-02 DK DK04801190.2T patent/DK1689775T3/da active
- 2004-12-02 ES ES04801190T patent/ES2369139T3/es not_active Expired - Lifetime
- 2004-12-02 PL PL06117339T patent/PL1752470T3/pl unknown
- 2004-12-02 CN CN200480036160.6A patent/CN1890264B/zh not_active Expired - Fee Related
- 2004-12-02 AT AT04801190T patent/ATE515269T1/de active
- 2004-12-02 AT AT06117339T patent/ATE439376T1/de active
- 2004-12-02 PT PT06117339T patent/PT1752470E/pt unknown
- 2004-12-02 SI SI200431257T patent/SI1752470T1/sl unknown
- 2004-12-02 SG SG200809009-4A patent/SG149000A1/en unknown
- 2004-12-02 EP EP10180974A patent/EP2270038A3/en not_active Withdrawn
- 2004-12-02 AU AU2004295104A patent/AU2004295104B2/en not_active Ceased
- 2004-12-02 SI SI200431747T patent/SI1689775T1/sl unknown
- 2004-12-02 WO PCT/EP2004/013670 patent/WO2005054285A1/en not_active Ceased
- 2004-12-02 PT PT04801190T patent/PT1689775E/pt unknown
- 2004-12-02 KR KR1020067013411A patent/KR101188785B1/ko not_active Expired - Fee Related
- 2004-12-02 EP EP06117339A patent/EP1752470B1/en not_active Expired - Lifetime
- 2004-12-02 EP EP04801190A patent/EP1689775B1/en not_active Expired - Lifetime
- 2004-12-02 PL PL04801190T patent/PL1689775T3/pl unknown
- 2004-12-02 DE DE602004022595T patent/DE602004022595D1/de not_active Expired - Lifetime
- 2004-12-02 NZ NZ547612A patent/NZ547612A/en not_active IP Right Cessation
- 2004-12-02 DK DK06117339T patent/DK1752470T3/da active
- 2004-12-02 KR KR1020127011106A patent/KR101278459B1/ko not_active Expired - Fee Related
- 2004-12-02 CA CA002546789A patent/CA2546789A1/en not_active Abandoned
- 2004-12-02 EP EP10174625A patent/EP2363411A1/en not_active Withdrawn
-
2006
- 2006-05-11 IL IL175565A patent/IL175565A0/en unknown
- 2006-06-05 US US11/422,169 patent/US7585937B2/en not_active Expired - Fee Related
-
2008
- 2008-06-02 US US12/131,311 patent/US7807413B2/en not_active Expired - Fee Related
-
2009
- 2009-05-07 US US12/437,121 patent/US20110144305A1/en not_active Abandoned
- 2009-10-08 CY CY20091101039T patent/CY1109480T1/el unknown
-
2010
- 2010-08-18 US US12/858,456 patent/US20100331237A1/en not_active Abandoned
-
2011
- 2011-09-16 CY CY20111100904T patent/CY1112330T1/el unknown
-
2012
- 2012-02-27 JP JP2012040123A patent/JP2012139226A/ja active Pending
- 2012-04-05 JP JP2012086483A patent/JP2012165747A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Thompson et al. | The ribosomal protein Asc1/RACK1 is required for efficient translation of short mRNAs | |
| Li et al. | Surface protein imprinted core–shell particles for high selective lysozyme recognition prepared by reversible addition–fragmentation chain transfer strategy | |
| JP2010529860A5 (cg-RX-API-DMAC10.html) | ||
| WO2007067730A3 (en) | Human monoclonal antibodies to protein tyrosine kinase 7 ( ptk7 ) and their use | |
| HUP0105337A2 (hu) | Az immunválaszban szerepet játszó új polipeptidek | |
| JP2007508034A5 (cg-RX-API-DMAC10.html) | ||
| WO2024138472A1 (zh) | 孔蛋白单体、孔蛋白及其突变体和其应用 | |
| Natalello et al. | Compact conformations of α‐synuclein induced by alcohols and copper | |
| Veglia et al. | The structure of the metal-binding motif GMTCAAC is similar in an 18-residue linear peptide and the mercury binding protein MerP | |
| EP2270038A3 (en) | GAG binding proteins | |
| Lind et al. | Post translational modifications in adenovirus type 2 | |
| WO2003065003A3 (en) | Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof | |
| Flood et al. | Assembly of nucleocapsids with cytosolic and membrane-derived matrix proteins of vesicular stomatitis virus | |
| Ospinal-Jimenez et al. | Structural analysis of protein denaturation with alkyl perfluorinated sulfonates | |
| WO2002012290A8 (en) | Sid polypeptides binding to pathogenic strain of the hepatitis c virus | |
| Westerhuis et al. | Reevaluation of the electrophoretic migration behavior of soluble globular proteins in the native and detergent-denatured states in polyacrylamide gels | |
| Lim et al. | The K15 protein of Kaposi's sarcoma-associated herpesvirus recruits the endocytic regulator intersectin 2 through a selective SH3 domain interaction | |
| WO2007052102A3 (en) | Modified green fluorescent proteins and methods for using same | |
| WO2003060098A3 (en) | Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to hiv-1 rna | |
| DK1297110T3 (da) | Attenueret bovin respiratorisk syncytialvirus | |
| Jeong et al. | Tuning oligovalent biomacromolecular interfaces using double-layered α-helical coiled-coil nanoassemblies from lariat-type building blocks | |
| Kiyokawa et al. | Engineering of the hydrophobic core of an α‐helical coiled coil | |
| JP2016505514A5 (cg-RX-API-DMAC10.html) | ||
| Agrawal et al. | SLAM (CD150) receptor homologous peptides block the peste des petits ruminants virus entry into B95a cells | |
| Ramos et al. | Proteomics based on peptide fractionation by SDS-free PAGE |